Viewing Study NCT01981161


Ignite Creation Date: 2025-12-24 @ 12:03 PM
Ignite Modification Date: 2026-01-24 @ 2:20 PM
Study NCT ID: NCT01981161
Status: COMPLETED
Last Update Posted: 2020-08-25
First Post: 2013-11-04
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Difference in Efficacy of Natalizumab Versus Fingolimod for the Treatment of Multiple Sclerosis
Sponsor: University Hospital, Toulouse
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module